News

$25.5m of new investment from a fund managed by Athyrium Capital Management

Achieving More Meaningful Patient Engagement in Rare Disease Trials

AbbVie and uMotif support Rheumatoid Arthritis patients with Bring Your Own Device approach to capturing study data

uMotif collaborates with The University of Manchester on body mapping tool

uMotif evolves leadership team with appointment of Steve Rosenberg as CEO

uMotif Adds eClinical Industry Veteran Steve Rosenberg to Board of Directors

uMotif and VirTrial partner to further expand decentralized clinical trial capabilities

AWS Case Study: The benefits and efficiencies of building the uMotif platform on Amazon Web Services infrastructure

On-Demand Webinar: Powering Virtual Trials – In the Cloud